BTA management has licenced to GSK. They may be retstircted to comment on Relenza under the licence.. It could be up to GSK to force retraction. When you licence something you do not legally control it during the period of the licence. This was half the beef re the court case
- Forums
- ASX - By Stock
- BTA
- press release sponsored by roche
press release sponsored by roche, page-12
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review